Replies to post #9312 on Seelos Therapeutics Inc (SEEL)

[eicoman]

Pascoe is trying to reverse the over selling and overly ambitious moves Damaj made, he is trying to get better deals with approvals on Vitaros first and FDA guidance on Femprox and narrow the number of partners. Pascoe stated National Phase approvals in EU would be Q4/Q1, 4 are already in, so I think he is trying to get ahead of guidance for once since this has been a big problem for APRI.